Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 18, 2017

View Archived Issues

Mustang Bio, Fred Hutch enter CAR-T therapy license agreement

GSK receives positive opinion for self-injectable formulation of Benlysta for SLE

Santhera receives negative opinion from CHMP for its Type II extension application for Raxone in DMD

Preclinical data on LTC4 synthase inhibitor AZD-9898 reported

CHMP adopts positive opinion for Zubsolv as treatment of opioid dependence

Cenderitide safe in phase I study in patients with left ventricular assist device support

TG Therapeutics begins phase III studies of ublituximab in MS

Massachusetts General Hospital, Dana-Farber and Harvard patent antifungal compounds

Roche describes novel cathepsin S inhibitors

Intarcia Therapeutics reports topline results from study of switch from liraglutide to ITCA-650

Ontario Institute for Cancer Research discovers WDR5-MLL protein binding inhibitors

Shanghai Pharmaceuticals Holding identifies new EGFR/ERBB2 inhibitors

Ontruzant becomes the first trastuzumab biosimilar to receive a positive opinion from CHMP

Phoenix Molecular Designs synthesizes novel ribosomal s6 kinase inhibitors

ThromboGenics to regain Jetrea rights from Alcon

CHMP adopts negative opinion for masitinib marketing authorization in indolent systemic mastocytosis

EMA committee recommends approval of guselkumab for moderate to severe plaque psoriasis

Boehringer Ingelheim receives positive opinion for adalimumab biosimilar Cyltezo

RNA-targeted therapy with MRG-201 found safe and feasible in rats

FDA grants orphan drug designation to iclaprim for S. aureus lung infections in cystic fibrosis

CHMP issues positive opinion for Zejula

Vesicular stomatitis virus expressing reovirus FAST protein shows anticancer activity

Daratumumab given U.S. orphan status for light-chain amyloidosis

FDA grants priority review to Braeburn's NDA for CAM-2038 for opioid use disorder

Circulating miRNA signature could aid in determining prognosis in NSCLC

FDA approves Somatuline Depot for carcinoid syndrome

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...